Abstract

In Sudan human leishmaniasis occurs in different clinical forms, that is, visceral (VL), cutaneous (CL), mucocutaneous (ML), and post-kala-azar dermal leishmaniasis (PKDL). Clinical samples from 69 Sudanese patients with different clinical manifestations were subjected to a PCR targeting the cytochrome oxidase II (COII) gene for Leishmania species identification. Mixed infections were suspected due to multiple overlapping peaks presented in some sequences of the COII amplicons. Cloning these amplicons and alignment of sequences from randomly selected clones confirmed the presence of two different Leishmania species, L. donovani and L. major, in three out of five CL patients. Findings were further confirmed by cloning the ITS gene. Regarding other samples no significant genetic variations were found in patients with VL (62 patients), PKDL (one patient), or ML (one patient). The sequences clustered in a single homogeneous group within L. donovani genetic group, with the exception of one sequence clustering with L. infantum genetic group. Findings of this study open discussion on the synergetic/antagonistic interaction between divergent Leishmania species both in mammalian and vector hosts, their clinical implications with respect to parasite fitness and response to treatment, and the route of transmission with respect to vector distribution and or adaptation.

Highlights

  • Leishmaniasis is a vector-borne parasitic disease caused by intramacrophage protozoa of the genus Leishmania, transmitted generally by at least 30 species of sand flies and rarely by congenital and parenteral routes [1, 2]

  • We report for the first time the detection of three cases of mixed L. donovani and L. major infections in three out of five patients diagnosed as cutaneous Leishmaniasis patients with no apparent clinical symptoms of visceral leishmaniasis (VL)

  • One hundred and eight samples composed of blood (HB), bone marrow (HBM), lymph node aspirates (HLN), extracted DNA and cultured parasites were obtained from 69 patients clinically suspected of leishmaniasis

Read more

Summary

Introduction

Leishmaniasis is a vector-borne parasitic disease caused by intramacrophage protozoa of the genus Leishmania, transmitted generally by at least 30 species of sand flies (either Phlebotomus or Lutzomyia genera) and rarely by congenital and parenteral routes [1, 2]. The disease is endemic in the tropical and subtropical regions of 88 countries [4, 5]. Population displacements and increasing cases of Leishmania/HIV coinfection brought new dramatic concerns to the disease especially in developing countries [6]. CL is caused by L. major and transmitted by Phlebotomus papatasi. It is endemic in the central and northern part of the country [13], recently, CL due to L. donovani has been well documented [14]. VL is the most serious form caused by Journal of Tropical Medicine

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call